...
首页> 外文期刊>Journal of cellular physiology. >RANKL triggers resistance to TRAIL-induced cell death in oral squamous cell carcinoma
【24h】

RANKL triggers resistance to TRAIL-induced cell death in oral squamous cell carcinoma

机译:抵抗TRAIL-induced细胞RANKL触发器死亡在口腔鳞状细胞癌

获取原文
获取原文并翻译 | 示例
           

摘要

Oral squamous cell carcinoma (OSCC) occurs as a malignancy of the oral cavity. RANK ligand (RANKL) is essential for osteoclast formation/bone resorption. Recently, we showed autoregulation of receptor activator of nuclear factor-kB ligand (RANKL) stimulates OSCC cell proliferation. OSCC cells show resistance to tumor necrosis factor related apoptosis inducing ligand (TRAIL) treatment. Therefore, we hypothesize that RANKL promotes resistance for TRAIL induction of OSCC apoptotic cell death. In this study, SCC14A and SCC74A cells cultured with TRAIL revealed high-level expression of RANKL which increased resistance to TRAIL inhibition of tumor cell proliferation. RANKL stimulation inhibited terminal deoxynucleotidyl transferase dUTP nick end labeling positive staining in TRAIL-treated cells. CRISPR/Cas-9 knockout of RANKL (RANKL-KO) increased caspase-9, caspase-3 activity and cytochrome c release in OSCC cells. RANKL inhibited proapoptotic proteins BAD and BAX expression. TRAIL treatment suppressed the SQSTMl/p62 and RANKL restored the expression. Interestingly, RANKL alone significantly increased proteasome activity. RANKL-KO in OSCC cells inhibited autophagic activity as evidenced by decreased light chain 3B-II and beclin-1 expression. Thus, RANKL stimulation of OSCC tumor cells triggered resistance for TRAIL-induced OSCC cell death. Taken together, blockade of RANKL may inhibit OSCC tumor progression and enhance the potential of TRAIL induced OSCC tumor cell apoptosis.
机译:口腔鳞状细胞癌(OSCC)发生口腔恶性肿瘤。(RANKL)对破骨细胞至关重要形成/骨吸收。自动调整的核受体激活factor-kB配体(RANKL)刺激OSCC细胞扩散。肿瘤坏死因子相关的凋亡诱导配体(TRAIL)治疗。假设RANKL促进阻力TRAIL诱导OSCC凋亡细胞死亡。这项研究中,SCC14A SCC74A细胞培养跟踪显示高级RANKL的表达增加抵抗TRAIL抑制肿瘤细胞增殖。抑制末端转移酶dUTP尼克结束标记阳性染色TRAIL-treated细胞。在OSCC细胞活性和细胞色素c的释放。RANKL抑制proapoptotic蛋白质坏和伯灵顿表达式。SQSTMl / p62和RANKL恢复了表情。有趣的是,RANKL显著蛋白酶体活性增加。细胞抑制自噬活动就是明证通过减少轻链3 b-ii和beclin-1表达式。细胞触发电阻TRAIL-induced OSCC细胞死亡。抑制OSCC肿瘤发展和提高小道OSCC诱导肿瘤细胞的潜力细胞凋亡。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号